(Q73531436)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Intermittent versus continuous clodronate administration in postmenopausal women with low bone mass (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

P Filipponi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Cristallini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G Policani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M F Schifini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C Casciari

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P Garinei

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

269-274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

The therapeutic use of bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Cyclical intravenous clodronate in postmenopausal osteoporosis: results of a long-term clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Effects of one-year cyclical treatment with clodronate on postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

The bone-remodeling transient: implications for the interpretation of clinical studies of bone mass change.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Short-term intravenous bisphosphonates in prevention of postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Effects of disodium dichloromethylene diphosphonate on bone loss in paraplegic patients

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Prevention of postmenopausal bone loss by tiludronate

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Intramuscular clodronate therapy in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

Sustained response to intravenous alendronate in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900273-2

7 January 2021

10.1016/S8756-3282(99)00273-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10710000%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference